Antibiotic usage in German hospitals: Results of the second national prevalence study

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 12, 2013, Pages 2934-2939

  Hansen, Sonja ^a,b   Sohr, Dorit ^a,b   Piening, Brar ^a,b   Diaz, Luis Pena ^a,b   Gropmann, Alexander ^a,b   Leistner, Rasmus ^a,b   Meyer, Elisabeth ^a,b   Gastmeier, Petra ^a,b   Behnke, Michael ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b National Reference Centre for Surveillance of Nosocomial Infections   (Germany)

Author keywords

Antibiotic usage; Germany; Prophylaxis; Treatment

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; ENZYME INHIBITOR; LINCOSAMIDE; MACROLIDE; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; COMMUNITY ACQUIRED INFECTION; DRUG INDICATION; DRUG UTILIZATION; GERMANY; HEALTH SURVEY; HOSPITAL; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; SINGLE DRUG DOSE; SURGICAL INFECTION; TREATMENT DURATION; UTILIZATION REVIEW;

ANTIBIOTIC USAGE; GERMANY; PROPHYLAXIS; TREATMENT;

ANTI-BACTERIAL AGENTS; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; GERMANY; HOSPITALS; HUMANS;

EID: 84887548380     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt292     Document Type: Article

References (28)

1. Zarb P, Amadeo B, Muller A et al. Identification of targets for quality improvement in antimicrobial prescribing: The web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother 2011; 66: 443-9.
2. Zarb P, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs 2011; 71: 745-55.
3. ECDC. Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals. Protocol Version 4.3. http://www.ecdc.europa.eu/en/publications/Publications/0512-TED-PPSHAI-antimicrobial-use-protocol.pdf (17 March 2013, date last accessed).
4. NRZ. Protocol of German Prevalence Survey. http://www.nrz-hygiene.de/ fileadmin/nrz/download/2011-09-02_EUPPS2011DE_Protokoll_v1.2.pdf (17 March 2013, date last accessed).
5. Statistisches Bundesamt (Destatis). List of Hospitals and Rehabilitation Clinics in Germany. http://www.destatis.de/DE/Publikationen/Thematisch/ Gesundheit/Krankenhaeuser/Krankenhausverzeichnis.html (17 March 2013, date last accessed).
6. Mielke M. First European point prevalence survey of healthcareassociated infections and antimicrobial use. Epidemiol Bull 2011; 19: 164-5.
7. WHO Collaborating Centre for Drug Statistics Methodology. The ATC/DDD System: International Language for Drug Utilization Research. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, October 2007. http:// www.fhi.no/dav/a0fb3024e7.pdf (17 May 2013, date last accessed).
8. German Recommendations of Good Epidemiological Practice. http:// www.gesundheitsforschung-bmbf.de/_media/Empfehlungen_GEP.pdf (17 March 2013, date last accessed).
9. German Protection Against Infection Act. http://www.gesetze-iminternet. de/ifsg/BJNR104510000.html (17 March 2013, date last accessed).
10. Spiegelhalter DJ. Funnel plots for comparing institutional performance. Statist Med 2005; 24: 1185-202.
11. Ruden H, Gastmeier P, Daschner F et al. Nosocomial infections in Germany. Their epidemiology in old and new Federal Lander. Dtsch Med Wochenschr 1996; 121: 1281-7.
12. StatistischesBundesamt (Destatis). BasicData on Hospitals 2012. http:// www.destatis.de/DE/Publikationen/Qualitaetsberichte/Gesundheitswesen/ Grunddatenkrankenhaueser.pdf (17 March 2013, date last accessed).
13. Hauer T, Lacour M, Gastmeier P et al. Nosocomial infections in Germany. Microbiological diagnosis, preventive antibioticsandantibiotic therapy.Med Klin (Munich) 1996; 91: 681-6.
14. RudenH.Nosocomial InfectionsinGermany-SurveillanceandPrevention. Band 56 der Schriftenreihe des Bundesministeriums für Gesundheit. Baden-Baden: Nomos Verlagsgesellschaft, 1995.
15. Ansari F, Erntell M, Goossens H et al. The European Surveillance of Antimicrobial Consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009; 49: 1496-504.
16. ECDC. Call for TenderOJ/2010/05/18-PROC/2010/024. Systematic Review andEvidence-basedGuidanceonPeri-operative Antibiotic Prophylaxis. http:// www.ecdc.europa.eu/en/aboutus/calls/Pages/ProcurementsandGrants.aspx (17 March 2013, date last accessed).
17. Hoffken G, Lorenz J, KernWet al. Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Communityacquired Pneumonia. Pneumologie 2010; 64: 149-54.
18. Reinhart K, Brunkhorst FM, Bone HG et al. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society and the German Interdisciplinary Association of Intensive Care and Emergency Medicine. Ger Med Sci 2010; 8: doi:10.3205/ 000103.
19. Schweickert B, Noll I, Feig M et al. MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood. Eur J Clin Microbiol Infect Dis 2012; 31: 1855-65.
20. Meyer E, Schwab F, Schroeren-Boersch B et al. Increasing consumption of MRSA-active drugs without increasing MRSA in German ICUs. Intensive Care Med 2011; 37: 1628-32.
21. Wagenlehner FM, Hoyme U, KaaseM et al. Uncomplicated urinary tract infections. Dtsch Arztebl Int 2011; 108: 415-23.
22. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficileassociated disease in North America and Europe. Clin Microbiol Infect 2006; 12 Suppl 6: 2-18.
23. Anon. German data of the first European prevalence survey of healthcare-associated infections and antimicrobial use. Epidemiol Bull 2012; 26: 239-41.
24. Meyer E, Gastmeier P, Weizel-Kage D et al. Associations between nosocomial meticillin-resistant Staphylococcus aureus and nosocomial Clostridium difficile-associated diarrhoea in 89 German hospitals. J Hosp Infect 2012; 82: 181-6.
25. Zarb P, Coignard B, Griskeviciene J et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill 2012; 17: pii=20316.
26. German Antibiotic Stewardship Initiative. http://www.antibioticstewardship. de/cms (17 March 2013, date last accessed).
27. Kern WV, de With K. Rational antibiotic prescribing. Challenges and successes. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2012; 55: 1418-26.
28. Revision of the German Protection Against Infection Act. http:// www.bmg.bund.de/praevention/krankenhausinfektionen/aenderung-desinfektionsschutzgesetzes. html (17 March 2013, date last accessed).